The Treatment of Children with Acute Megakaryoblastic Leukemia Who Have Down Syndrome
- 1 February 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 18 (1) , 10-12
- https://doi.org/10.1097/00043426-199602000-00003
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndromeBlood, 1994
- Myelodysplasia and acute megakaryoblastic leukemia in down's syndromeLeukemia Research, 1994
- Favorable treatment outcome in children with acute myeloid leukemia and Down syndrome [letter; comment]Blood, 1993
- Leukemia in newborn infants with down syndromeLeukemia Research, 1993
- Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498 [see comments]Blood, 1992
- Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesisBlood, 1992
- Leukemia in Down Syndrome: A ReviewPediatric Hematology and Oncology, 1992
- Perinatal Visceral Fibrosis Accompanying the Megakaryoblastic Leukemoid Reaction of Down SyndromePediatric Pathology, 1990
- Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study GroupThe Journal of Pediatrics, 1984
- Cytarabine: Low-Dose, High-Dose, No Dose?New England Journal of Medicine, 1983